摘要
慢性心力衰竭是各种心脏疾病的终末期表现,其患病率一直居高不下,预后较差。近年来,随着新型药物及其循证医学证据的不断涌现,心力衰竭药物治疗理念也在不断更新。该文综述了心力衰竭分型以及相关治疗药物、治疗理念的进展和突破,以期为临床治疗慢性心力衰竭提供参考依据。
Chronic heart failure(CHF)is an end-stage manifestation of various heart diseases with a high prevalence and a poor prognosis.In recent years,with a rapid emergence of new drugs and evidence-based medical evidence,the therapeutic concepts of heart failure drug are constantly updated.This review focused upon CHF classification,novel drugs and evolving conceptions of heart failure to provide references for a proper management of CHF.
作者
兰晨
苏文斌
颜霄迪
王倩
周琳
周玉皆
葛卫红
徐航
LAN Chen;SU Wenbin;YAN Xiaodi;WANG Qian;ZHOU Lin;ZHOU Yujie;GE Weihong;XU Hang(Department of Pharmacy,Nanjing Drum Tower Hospital,China Pharmaceutical University,Jiangsu Nanjing 210008,China;School of Basic Medicine&Clinical Pharmacy,China Pharmaceutical University,Jiangsu Nanjing 210009,China;Department of Respiratory Critical Care Medicine,Affiliated Nanjing Drum Tower Hospital,College of Medicine,Nanjing University,Jiangsu Nanjing 210008,China)
出处
《中国医院药学杂志》
CAS
北大核心
2024年第12期1467-1471,共5页
Chinese Journal of Hospital Pharmacy
关键词
心力衰竭
分型
药物治疗
研究进展
heart failure
classification
pharmacologic treatment
research progress
